Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals

Abstract Background The pathophysiology of Alzheimer’s disease (AD) involves $$\beta$$ β -amyloid (A $$\beta$$ β ) accumulation. Early identification of individuals with abnormal $$\beta$$ β -amyloid levels is crucial, but A $$\beta$$ β quantification with positron emission tomography (PET) and cere...

Full description

Bibliographic Details
Published in:	Alzheimer’s Research & Therapy
Main Authors:	Elaheh Moradi, Mithilesh Prakash, Anette Hall, Alina Solomon, Bryan Strange, Jussi Tohka, for the Alzheimer’s Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	BMC 2024-02-01
Subjects:	Machine learning Amyloid beta Conversion prediction Alzheimer’s disease Mild cognitive impairment
Online Access:	https://doi.org/10.1186/s13195-024-01415-w

Similar Items

Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease
by: Gustavo Patow, et al.
Published: (2023-12-01)

CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism
by: Ali Azargoonjahromi, et al.
Published: (2025-07-01)

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Self-Supervised Contrastive Learning to Predict the Progression of Alzheimer’s Disease with 3D Amyloid-PET
by: Min Gu Kwak, et al.
Published: (2023-09-01)

The effects of amyloid beta aggregation on neuronal transcription
by: Jesse St. Jean, et al.
Published: (2023-06-01)

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
by: Sheng-Min Wang, et al.
Published: (2024-03-01)

Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
by: Chae Jung Park, et al.
Published: (2022-09-01)

Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
by: Motonobu Fujishima, et al.
Published: (2024-04-01)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
by: Michael Ewers, et al.
Published: (2020-08-01)

Predicting cognitive dysfunction and regional hubs using Braak staging amyloid-beta biomarkers and machine learning
by: Puskar Bhattarai, et al.
Published: (2023-12-01)

Immune cell responses to amyloid-beta proteins: What is the extent and implications of amyloid-beta induced cytotoxicity in microglial cells and peripheral blood mononuclear cells?
by: Cao, A.
Published: (2017-07-01)

Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species
by: Cynthia J. Siebrand, et al.
Published: (2025-05-01)

Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: A meta-analysis
by: Fatemeh Sedghi, et al.
Published: (2025-12-01)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: O. Elaskalani, et al.
Published: (2018-05-01)

Olfactory Dysfunction Is Associated with Cerebral Amyloid Deposition and Cognitive Function in the Trajectory of Alzheimer’s Disease
by: Sheng-Min Wang, et al.
Published: (2023-08-01)

Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment
by: Takuya Ataka, et al.
Published: (2024-10-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
by: Guanan Zhao, et al.
Published: (2024-01-01)

Role of Graphene Oxide in Disentangling Amyloid Beta Fibrils
by: Brianna Duswalt, et al.
Published: (2024-10-01)

The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions
by: Thomas Gabriel Schreiner, et al.
Published: (2023-05-01)

Sleep is bi-directionally modified by amyloid beta oligomers
by: Güliz Gürel Özcan, et al.
Published: (2020-07-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
by: Giulia Arenare, et al.
Published: (2023-08-01)

A Copper-Selective Sensor and Its Inhibition of Copper-Amyloid Beta Aggregation
by: Ngoc Kim Nguyen, et al.
Published: (2024-05-01)

Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer’s Disease
by: Bin Zhou, et al.
Published: (2020-01-01)

Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour
by: Paolo Tucci, et al.
Published: (2022-08-01)

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
by: Davina Biel, et al.
Published: (2023-01-01)

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
by: Maria Luisa Moro, et al.
Published: (2018-01-01)

Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part B: Natural Compounds
by: Mariyana Atanasova
Published: (2025-09-01)

Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier
by: Dawn C. Matthews, et al.
Published: (2022-01-01)

Protein profiling and assessment of amyloid beta levels in plasma in canine refractory epilepsy
by: Sataporn Phochantachinda, et al.
Published: (2023-12-01)

Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model
by: Zhen-Dong Sun, et al.
Published: (2022-01-01)

Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part A: Endogenous Compounds and Repurposed Drugs
by: Mariyana Atanasova
Published: (2025-02-01)

Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells
by: Sehwan Jang, et al.
Published: (2022-01-01)

Tyramine and Amyloid Beta 42: A Toxic Synergy
by: Sudip Dhakal, et al.
Published: (2020-05-01)

Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
by: Alexandra Wicker, et al.
Published: (2024-10-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis
by: Zsolt Huszár, et al.
Published: (2024-04-01)

Lupeol protect against LPS-induced neuroinflammation and amyloid beta in adult mouse hippocampus
by: Kyonghwan Choe, et al.
Published: (2024-07-01)

Amyloid-beta and tau protein beyond Alzheimer’s disease
by: Morteza Abyadeh, et al.
Published: (2024-01-01)